Cover Image
Yun Zhang(Janssen (Belgium)), Chunling Jiang(Nanchang University), Qingfeng Mao(Nanchang University), Jinghui Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingao Li(Jiangxi Provincial Cancer Hospital), Shenggou Ding(Nanchang University), Weiliang Ying(Nanchang University), Jie Kuang, Yuling Huang, Yuxian Shu(Nanchang University)
Cited by 0
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Regulatory T cells in cardiovascular diseases
|Nature Reviews Cardiology|2015|410
Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
|Molecular Psychiatry|2019|191
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
|Journal of Clinical Oncology|2022|147
Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology
|Pharmaceutical Research|2007|125